Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Peripheral blood mononuclear cells of treated coeliac patients are known to liberate leucocyte migration inhibition factor when challenged with a synthetic dodecapeptide of the E1b protein of adenovirus 12 sharing sequence homology with A gliadin. This study has compared the response of the unfractionated peripheral blood mononuclear cells with a highly purified T cell population. Coeliac mononuclear cells and T lymphocytes showed identical leucocyte migration inhibition activity. The migration indices for the coeliac group were significantly different than for the control group irrespective of the cell population tested. This work justifies the use of the indirect leucocyte migration inhibition assay using mononuclear cell supernatants as a test of in vitro cell-mediated immunity to clearly defined antigens in coeliac disease. It also offers further evidence for the possible implication of adenovirus 12 in the pathogenesis of coeliac disease.


Journal article


Journal of clinical & laboratory immunology

Publication Date





75 - 79


Gastroenterology Unit, Radcliffe Infirmary, Oxford, UK.


T-Lymphocyte Subsets, Humans, Adenoviruses, Human, Celiac Disease, Peptide Fragments, Oncogene Proteins, Viral, Adenovirus Early Proteins, Gliadin, Antigens, Viral, Leukocyte Migration-Inhibitory Factors, Cell Migration Inhibition, Immunity, Cellular, Amino Acid Sequence, Sequence Homology, Nucleic Acid, Haplotypes, Molecular Sequence Data, Adult, Middle Aged, Female, Male